Singapore markets open in 7 hours 55 minutes

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
38.44-5.87 (-13.25%)
As of 12:05PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close44.31
Bid38.50 x 3200
Ask38.60 x 800
Day's range38.14 - 43.54
52-week range25.31 - 141.01
Avg. volume1,210,514
Market cap5.031B
Beta (5Y monthly)-1.44
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Glaxo (GSK), Vir COVID Drug Appears Effective Against Omicron

    Glaxo (GSK) and Vir Biotechnology announce promising pre-clinical data from the study of their antibody candidate, sotrovimab, against mutations found in the Omicron variant.

  • Motley Fool

    Why Vir Biotechnology Stock Is Soaring Today

    Shares of Vir Biotechnology (NASDAQ: VIR) were soaring 18.5% as of 11:08 a.m. ET on Tuesday. The big gain came after H.C. Wainwright analyst Patrick Trucchio boosted his price target on Vir from $135 to $200. Several analysts are bullish about Vir's prospects.

  • Motley Fool

    Why Vir Biotechnology Is Up More Than 13% Today

    Shares of biopharma company Vir Biotechnology (NASDAQ: VIR) are up 13.7% as of 11:57 a.m. ET on Monday in response to reports that a new strain of the COVID-19 virus has been identified. Indeed, headlines regarding the new omicron variant of the coronavirus began to surface before Thursday's Thanksgiving holiday. It just took a while for investors to connect the dots all the way back to Vir Biotechnology, which potentially benefits from a renewed outbreak of infections stemming from this new strain of the pandemic-causing virus.